Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Geropharm's Insulin Lispro Biphasic 25 vs Humalog Mix 25 in T2DM
NCT04023344Phase 3Completed
- Sponsor
- Geropharm
- Start
- Mar 2018
- Primary completion
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin lispro mix25 in type 2 diabetes mellitus (T2DM), sponsored by Geropharm. Started Mar 2018; status: completed.
02
Drugs
insulin lispro mix25
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04023344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04023344.